GANYMED Pharmaceuticals AG;TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
发明人:
申请号：
EP17171169.0
公开号：
EP3254695A1
申请日:
2013.05.21
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
